HiRO and Differentia Biotech collaborate on clinical trial simulation

HiRO and Differentia Biotech have signed a MoU outlining plans for a strategic partnership focused on clinical trial simulation. The collaboration will integrate HiRO’s data science and clinical operations experience with Differentia’s simulation platforms. HiRO founder and CEO Karen Chu; Differentia Biotech founder Shirley Wen. Credit: Harvest Integrated Research Organization (HiRO)/PRNewswire. Harvest Integrated Research Organization (HiRO) and Differentia Biotech have signed a memorandum of understanding (MoU) outlining plans for a strategic partnership focused on clinical trial simulation. The agreement was formalised at an event at HiRO’s office, as the two companies aim to combine expertise in clinical operations and AI-powered…

Source: Clinical Trials Arena